C. Fornasiero

New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.

A. Mortellaro, S. Songia, P. Gnocchi, 1999, Journal of immunology.

Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets.

A. Mantovani, E. Erba, S. Taverna, 1997, Journal of immunology.